Translated by: MOS Translation Team – Penelope
The National Pulse reported on January 4th that Lucy Xi, a scientist employed by GlaxoSmithKline (GSK), pleaded guilty to stealing trade secrets for a state-funded Chinese pharmaceutical company.
Xi and three co-defendants established Nanjing Renopharma with funding from the Chinese Communist Party (CCP). According to the U.S. Department of Justice, in January 2015, Xi sent her accomplice Mei Yan a GSK document containing “confidential and trade secret data and information”. It summarized GSK research into monoclonal antibodies, a lab-made molecule often treating the CCP virus.
In the email, Lucy Xi wrote, “You need to understand it very well. It will help you in your future business (Renopharma).”
U.S. attorney Williams noted, “This defendant illegally stole trade secrets to benefit her husband’s company, which was financed by the Chinese government… Such criminal behavior must be prosecuted to the fullest extent of the law.”
Proofread by: canyonsky
Edited by: canyonsky
Posted by: canyonsky
For more information, please follow us on:
Disclaimer: This article only represents the author’s view. Gnews is not responsible for any legal risks.